Stay updated on RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page’s displayed application/version identifier was updated from Revision: v3.5.2 to Revision: v3.5.3, reflecting a site update rather than a change to the trial record.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded revision v3.5.2 and removed revision v3.5.0 in the record history.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was added. Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded revision v3.4.3 and removed revision v3.4.2 from the history.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded Revision: v3.4.2 and removed notices including the older v3.4.1; these are minor metadata updates to the study record history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check81 days agoChange DetectedA site-wide notice about government funding status appears on the page and the page revision indicator updated from v3.4.0 to v3.4.1. These are system-level updates rather than changes to study content.SummaryDifference0.8%

Stay in the know with updates to RC48-ADC in HER2+ Biliary Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Biliary Cancer Clinical Trial page.